Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Midterm outcomes of subintimal angioplasty supported by primary proximal stenting for chronic total occlusion of the superficial femoral artery.

Hong SJ, Ko YG, Kim JS, Hong MK, Jang Y, Choi D.

J Endovasc Ther. 2013 Dec;20(6):782-91. doi: 10.1583/13-4398MR.1.

PMID:
24325694
2.
3.

Outcomes of spot stenting versus long stenting after intentional subintimal approach for long chronic total occlusions of the femoropopliteal artery.

Hong SJ, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, Jang Y.

JACC Cardiovasc Interv. 2015 Mar;8(3):472-480. doi: 10.1016/j.jcin.2014.10.016. Epub 2015 Feb 18.

4.

Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).

Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.

JACC Cardiovasc Interv. 2013 Dec;6(12):1295-302. doi: 10.1016/j.jcin.2013.07.010. Epub 2013 Nov 13.

5.
6.

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).

Matsumura JS, Yamanouchi D, Goldstein JA, Pollock CW, Bosiers M, Schultz GA, Scheinert D, Rocha-Singh KJ.

J Vasc Surg. 2013 Jul;58(1):73-83.e1. doi: 10.1016/j.jvs.2012.12.066. Epub 2013 May 2.

7.

German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization.

Krankenberg H, Tübler T, Sixt S, Fischer M, Schmiedel R, Schulte KL, Balzer JO, Kieback A, Fiehn E, Wittenberg G, Ali T, Tiefenbacher C, Jahnke T, Steinkamp HJ, Wegscheider K, Treszl A, Ingwersen M, Zeller T.

J Endovasc Ther. 2014 Aug;21(4):463-71. doi: 10.1583/13-4625R.1.

PMID:
25101571
8.

Results of iliac stenting and aortofemoral grafting for iliac artery occlusions.

Sachwani GR, Hans SS, Khoury MD, King TF, Mitsuya M, Rizk YS, Zachwieja JA, Sayed L.

J Vasc Surg. 2013 Apr;57(4):1030-7. doi: 10.1016/j.jvs.2012.09.038. Epub 2012 Nov 22.

9.

Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study.

Gandini R, Del Giudice C, Merolla S, Morosetti D, Pampana E, Simonetti G.

J Endovasc Ther. 2013 Dec;20(6):805-14. doi: 10.1583/13-4308MR.1.

PMID:
24325697
10.

Endovascular treatment for symptomatic stent failures in long-segment chronic total occlusion of femoropopliteal arteries.

Yang X, Lu X, Li W, Huang Y, Huang X, Lu M, Jiang M.

J Vasc Surg. 2014 Aug;60(2):362-8. doi: 10.1016/j.jvs.2014.02.051. Epub 2014 Mar 26.

11.

Retrograde popliteal approach for challenging occlusions of the femoral-popliteal arteries.

Ye M, Zhang H, Huang X, Shi Y, Yao Q, Zhang L, Zhang J.

J Vasc Surg. 2013 Jul;58(1):84-9. doi: 10.1016/j.jvs.2013.03.038.

12.

Retrograde transpopliteal recanalization of chronic superficial femoral artery occlusion after failed re-entry during antegrade subintimal angioplasty.

Noory E, Rastan A, Schwarzwälder U, Sixt S, Beschorner U, Bürgelin K, Neumann FJ, Zeller T.

J Endovasc Ther. 2009 Oct;16(5):619-23. doi: 10.1583/09-2784.1.

PMID:
19842727
13.

Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.

Schmieder GC, Richardson AI, Scott EC, Stokes GK, Meier GH 3rd, Panneton JM.

J Vasc Surg. 2008 Nov;48(5):1175-80; discussion 1180-1. doi: 10.1016/j.jvs.2008.05.080. Epub 2008 Sep 7.

14.

Endovascular nitinol stenting for long occlusive disease of the superficial femoral artery in critical limb ischemia: a single-center, mid-term result.

Hu H, Zhang H, He Y, Jin W, Tian L, Chen X, Li M.

Ann Vasc Surg. 2011 Feb;25(2):210-6. doi: 10.1016/j.avsg.2010.09.013.

PMID:
21315233
15.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.

Chan YC, Cheng SW, Cheung GC.

J Vasc Surg. 2015 Nov;62(5):1201-9. doi: 10.1016/j.jvs.2015.05.030. Epub 2015 Jul 11.

PMID:
26169015
16.

Endovascular treatment of lesions in the below-knee popliteal artery.

Siracuse JJ, Gill HL, Cassidy SP, Messina MD, Catz D, Egorova N, Parrack I, McKinsey JF.

J Vasc Surg. 2014 Aug;60(2):356-61. doi: 10.1016/j.jvs.2014.02.012. Epub 2014 Mar 18.

17.

First clinical experience with the Innova versus the Protege EverFlex self-expanding bare metal stents in superficial femoral artery occlusions.

Gabrielli R, Rosati MS, Chiappa R, Millarelli M, Marcuccio L, Siani A, Caselli G.

Thorac Cardiovasc Surg. 2015 Mar;63(2):158-63. doi: 10.1055/s-0034-1396898. Epub 2015 Jan 20.

PMID:
25602844
18.

Stent fractures after superficial femoral artery stenting: risk factors and impact on patency.

Lin Y, Tang X, Fu W, Kovach R, George JC, Guo D.

J Endovasc Ther. 2015 Jun;22(3):319-26. doi: 10.1177/1526602815580783. Epub 2015 Apr 10.

PMID:
25862365
19.

Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations.

Spiliopoulos S, Fragkos G, Katsanos K, Diamantopoulos A, Karnabatidis D, Siablis D.

J Endovasc Ther. 2012 Dec;19(6):788-96. doi: 10.1583/JEVT-12-3993R.1.

PMID:
23210878
20.

Primary stenting of the superficial femoral and popliteal artery.

Dearing DD, Patel KR, Compoginis JM, Kamel MA, Weaver FA, Katz SG.

J Vasc Surg. 2009 Sep;50(3):542-7. doi: 10.1016/j.jvs.2009.04.019. Epub 2009 Jun 21.

Supplemental Content

Support Center